Baudax Bio, Inc.
NANOPARTICULATE MELOXICAM FORMULATIONS

Last updated:

Abstract:

The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.

Status:
Application
Type:

Utility

Filling date:

5 Jun 2020

Issue date:

22 Apr 2021